UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | SEC 1473 (7-02) | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Option (right to buy) | Â (1) | 01/01/2017 | Common Stock | 48,000 | $ 31.5 | D | Â |
Option (right to buy) | Â (2) | 07/27/2017 | Common Stock | 16,000 | $ 16.5 | D | Â |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Watson Pacicco Kelli THE MEDICINES COMPANY 8 CAMPUS DRIVE PARSIPPANY, NJ 07054 |
 |  |  Senior Vice President |  |
/s/ Kelli Watson-Pacicco | 02/13/2008 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | As of 2/12/08, the original grant (48,000 shares granted on 1/1/07) was vested with respect to 13,000 of the shares covered thereby, none of which options had been exercised. The remaining 35,000 shares covered by this option vest in equal monthly installments ending on 1/1/11. |
(2) | As of 2/12/08, none of the options covered by the original grant (16,000 shares granted on 7/27/07) had vested. This grant vests 25% on 7/27/08 and in equal monthly installments thereafter ending on 7/27/11. |